| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | H0C805XYDE |
| InChI Key | GPKJTRJOBQGKQK-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C23H30ClN3O |
| Molecular Weight | 399.97 |
| AlogP | 5.97 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 37.39 |
| Molecular species | BASE |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 28.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | 100000 | - | - | 15 | |
|
Enzyme
Oxidoreductase
|
- | 10000 | - | 19000-19000 | - | |
|
Enzyme
Transferase
|
- | 20000 | - | - | 50-82 | |
|
Ion channel
Voltage-gated ion channel
Voltage-gated calcium channel
|
- | 5200 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | 3300 | - | - | 73 | |
|
Surface antigen
|
300 | - | - | - | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 4
|
- | - | - | - | 72 | |
|
Unclassified protein
|
- | - | 264 | 6700 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Creutzfeldt-Jakob Syndrome | 2 | D007562 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 83-89-6 |
| ChEBI | 8711 |
| ChEMBL | CHEMBL7568 |
| DrugBank | DB01103 |
| DrugCentral | 2338 |
| EPA CompTox | DTXSID7022627 |
| FDA SRS | H0C805XYDE |
| Human Metabolome Database | HMDB0015235 |
| Guide to Pharmacology | 10172 |
| KEGG | C07339 |
| PharmGKB | PA164745551 |
| PubChem | 237 |
| SureChEMBL | SCHEMBL19225 |